Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Nov 15;98(10):2414–2424. doi: 10.1172/JCI119055

Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine.

V Mooser 1, S M Marcovina 1, A L White 1, H H Hobbs 1
PMCID: PMC507694  PMID: 8941661

Abstract

Apolipoprotein(a) [apo(a)] contains multiple kringle 4 repeats and circulates as part of lipoprotein(a) [Lp(a)]. Apo(a) is synthesized by the liver but its clearance mechanism is unknown. Previously, we showed that kringle 4-containing fragments of apo(a) are present in human urine. To probe their origin, human plasma was examined and a series of apo(a) immunoreactive peptides larger in size than urinary fragments was identified. The concentration of apo(a) fragments in plasma was directly related to the plasma level of Lp(a) and the 24-h urinary excretion of apo(a). Individuals with low (< 2 mg/dl) plasma levels of Lp(a) had proportionally more apo(a) circulating as fragments in their plasma. Similar apo(a) fragments were identified in baboon plasma but not in conditioned media from primary cultures of baboon hepatocytes, suggesting that the apo(a) fragments are generated from circulating apo(a) or Lp(a). When apo(a) fragments purified from human plasma were injected intravenously into mice, a species that does not produce apo(a), apo(a) fragments similar to those found in human urine were readily detected in mouse urine. Thus, we propose that apo(a) fragments in human plasma are derived from circulating apo(a)/Lp(a) and are the source of urinary apo(a).

Full Text

The Full Text of this article is available as a PDF (576.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azrolan N., Gavish D., Breslow J. L. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J Biol Chem. 1991 Jul 25;266(21):13866–13872. [PubMed] [Google Scholar]
  2. Brunner C., Kraft H. G., Utermann G., Müller H. J. Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11643–11647. doi: 10.1073/pnas.90.24.11643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Callow M. J., Verstuyft J., Tangirala R., Palinski W., Rubin E. M. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J Clin Invest. 1995 Sep;96(3):1639–1646. doi: 10.1172/JCI118203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chiesa G., Hobbs H. H., Koschinsky M. L., Lawn R. M., Maika S. D., Hammer R. E. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem. 1992 Dec 5;267(34):24369–24374. [PubMed] [Google Scholar]
  5. Dieplinger H., Lackner C., Kronenberg F., Sandholzer C., Lhotta K., Hoppichler F., Graf H., König P. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest. 1993 Feb;91(2):397–401. doi: 10.1172/JCI116213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ernst A., Helmhold M., Brunner C., Pethö-Schramm A., Armstrong V. W., Müller H. J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem. 1995 Mar 17;270(11):6227–6234. doi: 10.1074/jbc.270.11.6227. [DOI] [PubMed] [Google Scholar]
  7. Farabaugh P. J. Alternative readings of the genetic code. Cell. 1993 Aug 27;74(4):591–596. doi: 10.1016/0092-8674(93)90507-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gaw A., Boerwinkle E., Cohen J. C., Hobbs H. H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest. 1994 Jun;93(6):2526–2534. doi: 10.1172/JCI117263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guyton J. R., Dahlen G. H., Patsch W., Kautz J. A., Gotto A. M., Jr Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis. 1985 May-Jun;5(3):265–272. doi: 10.1161/01.atv.5.3.265. [DOI] [PubMed] [Google Scholar]
  10. Haffner S. M., Gruber K. K., Aldrete G., Jr, Morales P. A., Stern M. P., Tuttle K. R. Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol. 1992 Nov;3(5):1156–1162. doi: 10.1681/ASN.V351156. [DOI] [PubMed] [Google Scholar]
  11. Hirata K., Kikuchi S., Saku K., Jimi S., Zhang B., Naito S., Hamaguchi H., Arakawa K. Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int. 1993 Nov;44(5):1062–1070. doi: 10.1038/ki.1993.349. [DOI] [PubMed] [Google Scholar]
  12. Hixson J. E., Britten M. L., Manis G. S., Rainwater D. L. Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons. J Biol Chem. 1989 Apr 15;264(11):6013–6016. [PubMed] [Google Scholar]
  13. Hoff H. F., O'Neil J., Yashiro A. Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions. J Lipid Res. 1993 May;34(5):789–798. [PubMed] [Google Scholar]
  14. Ikeo K., Takahashi K., Gojobori T. Different evolutionary histories of kringle and protease domains in serine proteases: a typical example of domain evolution. J Mol Evol. 1995 Mar;40(3):331–336. doi: 10.1007/BF00163238. [DOI] [PubMed] [Google Scholar]
  15. Koschinsky M. L., Beisiegel U., Henne-Bruns D., Eaton D. L., Lawn R. M. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry. 1990 Jan 23;29(3):640–644. doi: 10.1021/bi00455a007. [DOI] [PubMed] [Google Scholar]
  16. Koschinsky M. L., Côté G. P., Gabel B., van der Hoek Y. Y. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem. 1993 Sep 15;268(26):19819–19825. [PubMed] [Google Scholar]
  17. Koschinsky M. L., Tomlinson J. E., Zioncheck T. F., Schwartz K., Eaton D. L., Lawn R. M. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 1991 May 21;30(20):5044–5051. doi: 10.1021/bi00234a029. [DOI] [PubMed] [Google Scholar]
  18. Kraft H. G., Menzel H. J., Hoppichler F., Vogel W., Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest. 1989 Jan;83(1):137–142. doi: 10.1172/JCI113849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lackner C., Cohen J. C., Hobbs H. H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 1993 Jul;2(7):933–940. doi: 10.1093/hmg/2.7.933. [DOI] [PubMed] [Google Scholar]
  20. Lanford R. E., Carey K. D., Estlack L. E., Smith G. C., Hay R. V. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell Dev Biol. 1989 Feb;25(2):174–182. doi: 10.1007/BF02626175. [DOI] [PubMed] [Google Scholar]
  21. Linton M. F., Farese R. V., Jr, Chiesa G., Grass D. S., Chin P., Hammer R. E., Hobbs H. H., Young S. G. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest. 1993 Dec;92(6):3029–3037. doi: 10.1172/JCI116927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Liu A. C., Lawn R. M. Vascular interactions of lipoprotein (a). Curr Opin Lipidol. 1994 Aug;5(4):269–273. doi: 10.1097/00041433-199408000-00005. [DOI] [PubMed] [Google Scholar]
  23. Marcovina S. M., Albers J. J., Gabel B., Koschinsky M. L., Gaur V. P. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995 Feb;41(2):246–255. [PubMed] [Google Scholar]
  24. McLean J. W., Tomlinson J. E., Kuang W. J., Eaton D. L., Chen E. Y., Fless G. M., Scanu A. M., Lawn R. M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987 Nov 12;330(6144):132–137. doi: 10.1038/330132a0. [DOI] [PubMed] [Google Scholar]
  25. Menzel H. J., Dieplinger H., Lackner C., Hoppichler F., Lloyd J. K., Muller D. R., Labeur C., Talmud P. J., Utermann G. Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem. 1990 Jan 15;265(2):981–986. [PubMed] [Google Scholar]
  26. Mizuno K., Inoue H., Hagiya M., Shimizu S., Nose T., Shimohigashi Y., Nakamura T. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem. 1994 Jan 14;269(2):1131–1136. [PubMed] [Google Scholar]
  27. Mooser V., Seabra M. C., Abedin M., Landschulz K. T., Marcovina S., Hobbs H. H. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest. 1996 Feb 1;97(3):858–864. doi: 10.1172/JCI118487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. O'Reilly M. S., Holmgren L., Shing Y., Chen C., Rosenthal R. A., Moses M., Lane W. S., Cao Y., Sage E. H., Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994 Oct 21;79(2):315–328. doi: 10.1016/0092-8674(94)90200-3. [DOI] [PubMed] [Google Scholar]
  29. Oida K., Takai H., Maeda H., Takahashi S., Shimada A., Suzuki J., Tamai T., Nakai T., Miyabo S. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem. 1992 Nov;38(11):2244–2248. [PubMed] [Google Scholar]
  30. Parra H. J., Mezdour H., Cachera C., Dracon M., Tacquet A., Fruchart J. C. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem. 1987 May;33(5):721–721. [PubMed] [Google Scholar]
  31. Rainwater D. L., Manis G. S., VandeBerg J. L. Hereditary and dietary effects on apolipoprotein[a] isoforms and Lp[a] in baboons. J Lipid Res. 1989 Apr;30(4):549–558. [PubMed] [Google Scholar]
  32. Sandholzer C., Boerwinkle E., Saha N., Tong M. C., Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 1992 Mar;89(3):1040–1046. doi: 10.1172/JCI115645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Scanu A. M., Lawn R. M., Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med. 1991 Aug 1;115(3):209–218. doi: 10.7326/0003-4819-115-3-209. [DOI] [PubMed] [Google Scholar]
  34. Scanu A. M., Miles L. A., Fless G. M., Pfaffinger D., Eisenbart J., Jackson E., Hoover-Plow J. L., Brunck T., Plow E. F. Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37). J Clin Invest. 1993 Jan;91(1):283–291. doi: 10.1172/JCI116182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wang M. H., Skeel A., Leonard E. J. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest. 1996 Feb 1;97(3):720–727. doi: 10.1172/JCI118470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. White A. L., Rainwater D. L., Lanford R. E. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res. 1993 Mar;34(3):509–517. [PubMed] [Google Scholar]
  37. Yoshimura T., Yuhki N., Wang M. H., Skeel A., Leonard E. J. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem. 1993 Jul 25;268(21):15461–15468. [PubMed] [Google Scholar]
  38. Young S. G., Bertics S. J., Curtiss L. K., Witztum J. L. Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J Clin Invest. 1987 Jun;79(6):1831–1841. doi: 10.1172/JCI113025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van der Hoek Y. Y., Sangrar W., Côté G. P., Kastelein J. J., Koschinsky M. L. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. Arterioscler Thromb. 1994 Nov;14(11):1792–1798. doi: 10.1161/01.atv.14.11.1792. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES